| abstract |
A conjugate of a G-CSF moiety and one or more non-peptide water soluble polymers is provided. Typically, the non-peptide water soluble polymer is poly (ethylene glycol) or derivatives thereof. Furthermore, among these, a composition comprising the conjugate, a method of making the conjugate, and a method of administering a composition comprising the conjugate to a patient are provided. |